Through case-based discussions, this session aims to review facilitators and barriers to breastfeeding in parent-infant dyads affected by substance use and substance use disorder. Cases will highlight practical applications of the updated Academy of Breastfeeding Medicine Clinical Protocol #21: Breastfeeding in the Setting of Substance Use and Substance Use Disorder (Revised 2023).

ABM Grand Rounds is a live webinar program offered each month, addressing current clinical practice guidelines in the care of breastfeeding parents and infants. Webinars will be recorded and offered as on-demand content afterward in the ABM Education Center.

Check out the on-demand course preceding this one, ABM Grand Rounds: Breastfeeding in the Setting of Substance Use and Substance Use Disorder, here!

Academy of Breastfeeding Medicine Grand Rounds:

Web-based Enduring Material

Case Studies in Breastfeeding in the Setting of Substance Use

Dr. Miriam Harris and Dr. Elisha Wachman

Boston University School of Medicine 

Course Description: This series will address current clinical practice guidelines in the care of breastfeeding parents and infants. The Academy of Breastfeeding Medicine empowers health professionals to provide safe, inclusive, patient-centered, and evidence-based care. As a result of this activity, learners should be better able to address evolving issues in the clinical setting of breastfeeding medicine

Desired Outcomes:  

At the conclusion of this activity, participants should be able to:

• Identify current evidence-based recommendations for managing common medical issues that may impact breastfeeding success
• Develop a global perspective on issues and treatments in breastfeeding medicine

Speaker Learning Objectives:

1. Review strategies to reduce harm of substance use while breastfeeding
2. Identify opportunities to support initiating breastfeeding in parent-infant dyads affected by substance use or substance use disorder
3. Examine ways to support breastfeeding after initial hospitalization in parent-infant dyads affected by substance use or substance use disorder

Effective Date: March 2024

Expiration Date: December 2025

Learning medium: to receive credit, participants will need to watch the video

Target Audience: Providers in Family Medicine, Ob/Gyn, Pediatrics, and Lactation Consultants

Accreditation:

Jointly Provided by the University of Virginia School of Medicine and School of Nursing and the Academy of Breastfeeding Medicine

In support of improving patient care, this activity has been planned and implemented by the Academy of Breastfeeding Medicine and the University of Virginia School of Medicine and School of Nursing. The University of Virginia School of Medicine and School of Nursing is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Virginia School of Medicine and School of Nursing designates this live activity for a maximum of 1 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Virginia School of Medicine and School of Nursing awards 1hour of participation (consistent with the designated number of AMA PRA Category 1 Credit(s)^TM  or ANCC contact hours) to a participant who successfully completes this live educational activity. The University of Virginia School of Medicine and School of Nursing maintains a record of participation for six (6) years.

Full Disclosure Policy Affecting CME Activities:  As a joint accredited provider, the University of Virginia Office of CME/CE requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME.

No one in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with any commercial interest.

Disclosure of faculty financial affiliations

The University of Virginia School of Medicine and School of Nursing as a Joint Accreditation Provider adhere to the ACCME Standards for Integrity and Independence in Accredited Continuing Education, released in December 2020, as well as Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines. As the accredited provider for this CE/IPCE activity, we are responsible for ensuring that healthcare professionals have access to professional development activities that are based on best practices and scientific integrity that ultimately supports the care of patients and the public.

All individuals involved in the development and delivery of content for an accredited CE/IPCE activity are expected to disclose relevant financial relationships with ineligible companies occurring within the past 24 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.).  The University of Virginia School of Medicine and School of Nursing employ appropriate mechanisms to resolve potential conflicts of interest and ensure the educational design reflects content validity, scientific rigor and balance for participants.  Questions about specific strategies can be directed to the University of Virginia School of Medicine and School of Nursing of the University of Virginia, Charlottesville, Virginia.

The faculty, staff, CE Advisory Committee and planning committee engaged in the development and/or peer review of this CE/IPCE activity in the Joint Accreditation CE Office of the School of Medicine and School of Nursing have no financial affiliations to disclose.

Disclosure of discussion of non-FDA approved uses for pharmaceutical products and/or medical devices

As a Joint Accreditation provider, the University of Virginia School of Medicine and School of Nursing, requires that all faculty presenters identify and disclose any off-label or experimental uses for pharmaceutical and medical device products. It is recommended that each clinician fully review all the available data on new products or procedures prior to clinical use.